Live Breaking News & Updates on Arrowhead Pharmaceuticals Conference Call|Page 2

Stay updated with breaking news from Arrowhead pharmaceuticals conference call. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Arrowhead Pharmaceuticals, Inc (ARWR) Q2 2021 Earnings Call Transcript


Operator
Ladies and gentlemen welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today s recorded presentation all participants will be in a listen-only mode. After the presentation, there will be an opportunity to ask questions.
I will now hand the conference call over to Vincent Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead Vince.
Vincent Anzalone
Vice President of Investor Relations
Thank you, Jessi. Good afternoon everyone. Thank you for joining us today to discuss Arrowhead s results for it s Fiscal 2021 Second Quarter ended March 31, 2021. With us today from management are President and CEO, Dr. Christopher Anzalone, who will provide an overview of the quarter; Dr. Javier San Martin, our Chief Medical Officer, who will provide an update on our pipeline; and Ken Myszkowski, our Chief Financial Officer, who will give a review of the financials. In addition, James Hassard, our Chief Commercial Officer, and ....

United States , Ken Myszkowski , James Hassard , Vincent Anzalone , James Hamilton , Christopher Anzalone , Society International Research Congress , Arrowhead Pharmaceuticals Conference Call , Securities Exchange , Arrowhead Pharmaceuticals Inc , Arrowhead Pharmaceuticals , Arrowhead Pharmaceuticals Conference , Vice President , Investor Relations , Javier San Martin , Chief Medical Officer , Chief Financial Officer , Chief Commercial Officer , Senior Vice President , Translational Medicine , Securities Act , Securities Exchange Act , Chief Executive , Single Ascending Dose , Cystic Fibrosis , International Research Congress ,